Plain-English translation of NCT07673107 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
United States
Phase
Testing effectiveness
Sponsor
AbbVie
Enrollment target
~94 participants
Started
June 2026
Primary completion
November 2028
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
ABBVIE CALL CENTER
AbbVie
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.